Virginia Commonwealth University

NEW YORK (GenomeWeb) – A research team at Virginia Commonwealth University has received a $6.9 million grant from the National Institute on Alcohol Abuse and Alcoholism to expand its research program examining the molecular and genetic causes of alcohol abuse and alcoholism.

NEW YORK (GenomeWeb) – Researchers at Virginia Commonwealth University have reeled in a $3 million grant from the National Institute of Mental Health to investigate whether adverse experiences during childhood leave molecular marks that potentially could be used in diagnostic tests to predict hea

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

NEW YORK (GenomeWeb News) – A study appearing online in JAMA Psychiatry suggests methylation marks in and around dozens of genes may serve as biomarkers for schizophrenia, providing potential clue

Researchers from Virginia Commonwealth University are planning a study of DNA methylation, with the hope that it will yield a molecular signature that can be used to personalize treatment for depression by distinguishing those who are likely to have a chronic form of the disease

Protea, VCU Collaborating to Improve Molecular Imaging For Various Diseases

NEW YORK (GenomeWeb News) – Protea Biosciences said today that it has entered into a collaborative research agreement with Virginia Commonwealth University and its Center for Molecular Imaging focused on improved molecular imaging techniques for the study of cancer, Alzheimer's, and other disease

NEW YORK (GenomeWeb News) – Three research projects will use $22.1 million in National Institutes of Health funding to fuel new studies under the Human Microbiome Project program to investigate how microbiome changes in the body may influence the human hosts' physiologies, NIH said today.

The study, which involves a cohort of 1,500 patients and controls, is using a whole-genome approach to find methylation patterns associated with schizophrenia.

The collaboration, which will use Life Technologies' SOLiD System and MethylMiner methylated DNA enrichment kit, will study how gene regulation and epigenetic markers may be involved in the development of schizophrenia.

Pages

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.